Novartis Reports Positive Phase III Results for Remibrutinib in Chronic Spontaneous Urticaria
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has announced positive data from the Phase III...
Burning Rock Partners with AstraZeneca to Develop Companion Diagnostics for Cancer Therapies
Guangzhou-based medical device giant Burning Rock (NASDAQ: BNR) has announced a strategic partnership with AstraZeneca...
Audit Reveals Illicit Payments and Inflated Prices in Pharmaceutical Industry
An audit has shed light on the use of third-party business promotion companies as a...
Eli Lilly & Co. Reports 28% YOY Revenue Increase in Q2 2023 Financials
US pharmaceutical giant Eli Lilly & Co., (NYSE: LLY) has released its financial results for...
FibroGen’s Evrenzo Achieves Record Sales in China, Outlook for 2024 Remains Promising
US-based biopharmaceutical company FibroGen Inc., (NASDAQ: FGEN) has released its financial report for the second...
Bayer AG Reports Q2/H1 2023 Financials with Challenges in Crop Science and Pharmaceuticals
Germany-based multinational Bayer AG (ETR: BAYN) has released its financial report for the second quarter...
Novo Nordisk’s Wegovy Demonstrates 20% Reduction in Cardiovascular Events in SELECT Trial
Denmark-based pharmaceutical giant Novo Nordisk A/S (NYSE: NVO) has released topline data supporting the use...
Shanghai Health Commission Issues Regulations to Curb Unhealthy Pharmaceutical Practices
In alignment with the No. 75 Document by the National Health Commission, the Shanghai...
CanSino Biotechnology Partners with AstraZeneca for mRNA Vaccine Development and Manufacturing
China-based vaccines specialist CanSino Biologics Inc., (HKG: 6185) has announced a product supply cooperation framework...
Lynk Pharmaceuticals’ LNK01001 Shows Positive Results in Atopic Dermatitis Phase II Study
China-based Lynk Pharmaceuticals Co., Ltd has announced that its Phase II clinical study for LNK01001...
BioNTech Expands Partnership with Duality Biologics for Global Rights to ADC DB-1305
Germany-based BioNTech SE (NASDAQ: BNTC) has entered into a cooperation expansion agreement with its existing...
Johnson & Johnson Reaches Settlement with Fresenius Kabi and Formycon AG for Stelara Biosimilar
US pharmaceutical giant Johnson & Johnson (J&J; NYSE: JNJ) has entered into its latest settlement...
VistaGen’s Fasedienol Phase III Success Sends Shares Soaring Over 600%
Shares of San Francisco-based biotech VistaGen (NASDAQ: VTGN) experienced a dramatic increase of over 600%...
Nektar Therapeutics and Eli Lilly & Co. Face Off in Court Over REZPEG Partnership Dispute
A legal feud between US-based Nektar Therapeutics (NASDAQ: NKTR) and pharmaceutical giant Eli Lilly &...
BioCity Biopharma Receives FDA IND Approval for CD3-EGFR BsAb BC3448
China-based biotechnology company BioCity Biopharma has announced that it has received Investigational New Drug (IND)...
Zai Lab Ltd Reports Q2 2023 Financials with 53% YOY Product Revenue Growth
China-based Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688) has released its financial results for the...
Beijing’s Gene Cradle Secures Pre-Series B+ Funding Led by Cash Capital
Gene Cradle, a Beijing-based gene therapy specialist, has reportedly secured tens of millions of renminbi...
Gracell Biotechnologies Secures $100 Million in Private Placement with Healthcare Investors
Suzhou-based biotech firm Gracell Biotechnologies Inc., (NASDAQ: GRCL) has announced a purchase agreement with a...
National Health Commission Unveils 10 Measures to Enhance Primary Healthcare Services
The National Health Commission has issued a Notice outlining “Measures for Grassroots Health and Convenient...
Biogen and Sage Therapeutics Receive FDA Approval for Postpartum Depression Treatment Zurzuvae
Biogen Inc., (NASDAQ: BIIB) and its partner Sage Therapeutics Inc., (NASDAQ: SAGE) have announced that...